Searchable abstracts of presentations at key conferences in endocrinology

ea0032p1051 | Thyroid (non-cancer) | ECE2013

The influence of thyroid hormones on the variability of blood pressure

Nisic Tanja , Stojanovic Milos , Stojkovic Mirjana , Beleslin Biljana , Ciric Jasmina , Lalic Tijana , Trbovic Bozo , Zarkovic Milos

Introduction: Changes in thyroid function have significant impact on the cardiovascular system.Methods: In a group of 37 subjects the level of thyroid hormones FT4, FT3, and TSH were measured. Then carried out short-term analysis for 30 min measureing variability of blood pressure with non-invasive TASK FORCE monitor. Registered data were analyzed by spectral analysis of variability. Statistical analysis were done by Pearson correla...

ea0022oc4.6 | Adrenals | ECE2010

Serum cortisol predicts increased cardiovascular mortality in patients with acute coronary syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study

Tomaschitz Andreas , Pilz Stefan , Ritz Eberhard , Grammer Tanja , Drechsler Christiane , Boehm Bernhard , Maerz Winfried

Over the past several years, growing evidence suggested that serum cortisol is associated with increased cardiovascular (CVD) mortality in patients with chronic heart failure. The prognostic significance of serum cortisol concentration (SCC) in patients with acute coronary syndrome (ACS) however is unknown.In the prospective Ludwigshafen Risk and Cardiovascular Health (LURIC) study 3316 patients (median age: 63.5 (56.3–70.6) years; 30.2% women) were...

ea0056p663 | Growth hormone IGF axis - basic | ECE2018

IGF-1 corellates with cognitive status in esrd patients undergoing haemodialysis

Prelevic Vladimir , Radunovic Danilo , Antunovic Tanja , Ratkovic Marina , Gligorovic-Barhanovic Najdana , Vujosevic Snezana

Backrounds: Prevalence of cognitive function decline in End Stage Renal Disease (ESRD) patients undergoing hemodialysis is higher than in general population. We analyzed risk factors for cognitive function decline in those patients.Study design: This study included 93 ESRD patients undergoing hemodialysis two or three times a week in Center for hemodialysis, Clinical center of Montenegro and two regional centers for hemodialysis in Montenegro. The cognit...

ea0056p884 | Pituitary - Clinical | ECE2018

Clinical and treatment outcomes in patients with craniopharyngiomas – single center experience

Polovina Tanja Skoric , Solak Mirsala , Kraljevic Ivana , Dusek Tina , Spanovic Nemanja , Balasko Anne-Marie , Kastelan Darko

Craniopharyngiomas are rare and histologically benign tumors that are associated with an unfavourable prognosis and controversial optimal treatment. The aim of this retrospective study was to review clinical presentation, natural history and therapeutic outcomes of patients with craniopharyngiomas treated in a single center between 1995 and 2017. In that period, 38 patients (16 children and 22 adults) were diagnosed with craniopharyngioma. Median age at the time of diagnosis i...

ea0093oc18 | Oral communication 3: Adrenal Tumors and Neuroendocrine Tumors | EYES2023

Towards an understanding of the microenvironment of ACC: Impact of steroid hormones and driver pathways

Maier Tanja , Landwehr Laura-Sophie , Sbiera Silviu , Schauer Marc P. , Schwarzmuller Paul , Fassnacht Martin , Kroisz Matthias

Background: Immune checkpoint therapy response rate in adrenocortical carcinoma (ACC) is only ~15%. Glucocorticoid (GC) secretion is present in ~60% of tumours, associated with adverse outcome and has been associated with an immunologically cold tumoural microenvironment. On the other hand, activation of the Wnt/ß-Catenin pathway has been suggested to contribute to reduced immune infiltration.Aims: First, we aim to improve the understanding of cellu...

ea0099ep943 | Reproductive and Developmental Endocrinology | ECE2024

Implications of x-linked adrenoleukodystrophy in different family members

Tonkic Luciana , Miličević Milardović Tanja , Novak Anela

Adrenoleukodystrophy (ALD) is a monogenic, X-linked hereditary disorder. Mutation in the ABCD1 gene results in the adrenoleukodystrophy protein (ALDP) deficiency which is involved in the intracellular transport and metabolism of very long-chain fatty acids (VLCFAs). Consequently, VLCFAs accumulate in the central and peripheral nervous systems and adrenal glands leading to the destruction of affected tissues and specific symptoms and signs. There are four distinct types of ALD ...

ea0011p295 | Diabetes, metabolism and cardiovascular | ECE2006

Metabolic syndrome and insulin sensitivity in early glycoregulation disorders

Vesna Dimitrijevic-Sreckovic VDS , Predrag Djordjevic PDJ , Srdjan Popovic SP , Drasko Gostiljac DG , Fadil Canovic FC , Branko Sreckovic BS , Miroljub Ilic MI , Tanja Novakovic TN , Emina Colak EC , Radmila Obrenovic RO , Gordana Milic GM , Tanja Nisic TN , Visnja Panasiuk VP

Background and Aims: Early glycoregulation disorders, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are associated with metabolic syndrome (MS). The aim of this study is: (a) to analyze parameters of insulin sensitivity, glycoregulation, lipid status, microalbuminuria (MI) and homocysteine (HCY) in patients with obesity (I), IFG (II), IGT (III) and newly diagnosed DM type 2 (IV) patients; (b) to determine the percentage of metabolic syndrome at these pati...

ea0099p505 | Endocrine-Related Cancer | ECE2024

Growth differentiation factor 15 (GDF-15) is induced by mitotane in adrenocortical carcinoma and associated with poor prognosis and impaired responsiveness to immunotherapy

Weigand Isabel , Triebig Alexandra , Tanja Maier , Anderlik Tanja , Remde Hanna , Landwehr Laura-Sophie , Kimpel Otilia , Reuter Miriam , Schreiner Jochen , Wedekink Florian , Hoster Eva , Schwarzlmueller Paul , Reincke Martin , Wischhusen Jorg , Fassnacht Martin , Matthias Kroiss

Background: Treatment of adrenocortical carcinoma (ACC) is unsatisfactory in advanced stages. Oral mitotane remains a mainstay of treatment. Response rates of ACC to immune checkpoint inhibition (ICI) are disappointing and markers of response have not been identified. Tumoural infiltration with cells of the adaptive immune system is sparse in ACC tissue. Growth/differentiation factor 15 (GDF-15) is a cytokine that has been described to impair tumoral immune infiltration and is...

ea0081rc7.1 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2022

Does the postoperative dose of hydrocortisone influence the health-related quality of life in patients with cured Cushing syndrome?

Kraljevic Ivana , Barac Anja , Solak Mirsala , Skoric Polovina Tanja , Balasko Annemarie , Zibar Tomsic Karin , Dusek Tina , Kastelan Darko

Objective: Patients with Cushing syndrome (CS) have impaired health-related quality of life (HRQoL) before and after surgery. The data on the optimal hydrocortisone dose after surgical cure of CS is scarce. Therefore, we investigated the influence of hydrocortisone dose on HRQoL after surgical treatment of CS. We hypothesized that patients who receive higher hydrocortisone doses after surgery would have better HRQoL and fewer cortisol withdrawal symptoms.<p class="abstext"...

ea0063p1092 | Pituitary and Neuroendocrinology 3 | ECE2019

Factors predicting dopamine agonist treatment withdrawal in prolactinoma patients

Solak Mirsala , Haxhiu Arta , Haxhiu Arita , Kraljevic Ivana , Dusek Tina , Leskovar Dunja , Polovina Tanja Skoric , Balasko Annemarie , Kastelan Darko

Aim: Dopamine agonist (DA) therapy is recommended as first-line treatment for prolactinomas, albeit with long treatment duration and high recurrence rate after treatment withdrawal. The aim of this retrospective study was to evaluate predictors for successful DA withdrawal.Methods: The study included 59 prolactinoma patients (39 female, 20 male; age 34 (18–82) years) that were treated with DA (35.6% on cabergoline); the duration of treatment was 71 ...